What is the standard of care for early stage Prostate Cancer according to NCCN guidelines

Standard of Care for Early-Stage Prostate Cancer (NCCN Guidelines)

The NCCN (National Comprehensive Cancer Network) takes a nuanced approach to early-stage prostate cancer, emphasizing that one size does not fit all. The standard of care depends heavily on your risk category.

Risk-Based Treatment Approach

According to NCCN Guidelines, doctors first categorize early-stage prostate cancer into risk groups:

• Very Low Risk
• Low Risk
• Intermediate Risk (further divided into favorable and unfavorable)
• High Risk or Very High Risk

Your specific risk category—determined by factors like PSA level, Gleason score, and extent of cancer—drives treatment recommendations.

Key Treatment Options by Risk Level

For Lower-Risk Disease

NCCN emphasizes an important principle: avoiding overtreatment. For many patients with lower-risk prostate cancer, the standard of care includes:

• Active Surveillance - Regular monitoring with PSA tests and biopsies rather than immediate treatment
• Observation - Watchful waiting approach
• Surgery (Radical Prostatectomy) - Surgical removal of the prostate
• Radiation Therapy - External beam radiation or other radiation approaches

For Higher-Risk Disease

Treatment becomes more aggressive. The standard of care typically includes:

• Surgery with Pelvic Lymph Node Dissection (PLND) - Removal of nearby lymph nodes to check for cancer spread
• Adjuvant Therapy - Additional treatment after initial surgery to prevent recurrence, which may include:
  • Radiation therapy to the prostate bed
  • Long-term hormone therapy (androgen deprivation therapy or ADT)

Important NCCN Principle

According to NCCN Guidelines, all patients choosing active surveillance should have a confirmatory prostate biopsy 1 to 2 years after their initial biopsy to ensure the cancer hasn't changed.

Questions to Ask Your Oncologist

1. What is my specific risk category, and how was it determined?
2. What are the pros and cons of each treatment option for MY situation?
3. If I choose active surveillance, what monitoring schedule would you recommend?
4. If I need surgery, will you perform a pelvic lymph node dissection?
5. What adjuvant (additional) treatments might be recommended after my initial treatment?

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.